Clinical Trial

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Recruiting
View on ClinicalTrials.gov →
Summary
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-28; most recent amendment 2026-05-28.
Trial Details
NCT Number NCT07102082
Lead Sponsor Roswell Park Cancer Institute
Collaborators: National Cancer Institute (NCI)
Conditions Smoking Behaviors
Enrollment 160 participants
Start Date 2025-09-25
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-01